Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas

NCT00152126 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma
Central Nervous System Tumors
Lymphomas
Wilms Tumor

Interventions

PROCEDURE: Stem Cell Transplantation
DRUG: Busulfan, Melphalan

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]